Three molecules present in osteoblasts have been identified, by means of gene knock-out models, as affecting the controlled deposition of bone mineral i.e., alkaline phosphatase (TNAP); PC-1 (or Npps, a nucleoside triphosphate pyrophosphate hydrolase isozyme, NTPPPH) and the and gene product. Our preliminary results indicate that primary osteoblasts from TNAP-/- hyphosphastasia mice have increased levels of inorganic pyrophosphate (PPi), a known inhibitor of mineralization, in their matrix vesicles (MVs). PPi is produced by the action of the ANK protein. The central hypotheses to be tested in this proposal are that TNAP's key function in bone degradation of PPi to remove the mineralization inhibitor. We further hypothesize that PC-1 is a direct antagonist of TNAP function but also that ANK may antagonize TNAP-dependent matrix calcification. Furthermore, we propose that loss of function of two distinct skeletal TNAP antagonists, PC-1 and ANK, will ameliorate TNAP deficiency-associated osteomalacia in vivo. Conversely, we propose that the hyperossification associated with both PC-1 null mice and ANK-deficient (ank/ank) mice will be ameliorated by loss of function of TNAP in vivo. Thus, our Specific Aims are: I. To test the hypothesis that the PC-1 and TNAP deficiencies are mutually rescued by cross-breeding; II. To test the hypothesis that ank/ank and TNAP null mice are also mutually rescued by cross breeding; III. To test the hypothesis that levels of intracellular and extracellular PPi are central regulators of the expression of the genes (PC-1, TNAP, and ANK) that regulate PPi production, degradation and secretion. The proposal will define the potential for TNAP and PC-1/ANK to serve as counter-regulatory factors controlling bone mineralization through effects on PPi metabolism, and thereby also address the relative contribution of the effects on PPi metabolism to the ability of TNAP, PC-1 and ANK to regulate bone mineralization. Completion of these studies will potentially provide therapeutic approaches to disorders of both decreased and increased matrix mineralization.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR047908-02
Application #
6623885
Study Section
Special Emphasis Panel (ZRG1-OBM-2 (01))
Program Officer
Sharrock, William J
Project Start
2002-05-01
Project End
2007-02-28
Budget Start
2003-03-01
Budget End
2004-02-29
Support Year
2
Fiscal Year
2003
Total Cost
$384,605
Indirect Cost
Name
Sanford-Burnham Medical Research Institute
Department
Type
DUNS #
020520466
City
La Jolla
State
CA
Country
United States
Zip Code
92037
McKee, Marc D; Hoac, Betty; Addison, William N et al. (2013) Extracellular matrix mineralization in periodontal tissues: Noncollagenous matrix proteins, enzymes, and relationship to hypophosphatasia and X-linked hypophosphatemia. Periodontol 2000 63:102-22
Simão, Ana Maria S; Bolean, Maytê; Hoylaerts, Marc F et al. (2013) Effects of pH on the production of phosphate and pyrophosphate by matrix vesicles' biomimetics. Calcif Tissue Int 93:222-32
Kiffer-Moreira, Tina; Narisawa, Sonoko (2013) The use of tissue-nonspecific alkaline phosphatase (TNAP) and PHOSPHO1 inhibitors to affect mineralization by cultured cells. Methods Mol Biol 1053:125-34
Narisawa, Sonoko; Yadav, Manisha C; Millan, Jose Luis (2013) In vivo overexpression of tissue-nonspecific alkaline phosphatase increases skeletal mineralization and affects the phosphorylation status of osteopontin. J Bone Miner Res 28:1587-98
Millan, Jose Luis (2013) The role of phosphatases in the initiation of skeletal mineralization. Calcif Tissue Int 93:299-306
Foster, B L; Nagatomo, K J; Tso, H W et al. (2013) Tooth root dentin mineralization defects in a mouse model of hypophosphatasia. J Bone Miner Res 28:271-82
Kiffer-Moreira, Tina; Yadav, Manisha C; Zhu, Dongxing et al. (2013) Pharmacological inhibition of PHOSPHO1 suppresses vascular smooth muscle cell calcification. J Bone Miner Res 28:81-91
Yadav, Manisha C; de Oliveira, Rodrigo Cardoso; Foster, Brian L et al. (2012) Enzyme replacement prevents enamel defects in hypophosphatasia mice. J Bone Miner Res 27:1722-34
Sheen, Campbell R; Pilarowski, Genay O W; Wang, Wei et al. (2012) Molecular characterisation of the Hyp deletion and an improved assay for its detection. Bone 50:592-5
Millan, J L (2012) Mechanisms of initiation of skeletal mineralization: the role of phosphatases. Bull Group Int Rech Sci Stomatol Odontol 51:e6-7

Showing the most recent 10 out of 37 publications